GLP1R gene variant is associated with glycaemic response to treatment with DPP-4 inhibitors

被引：0
|
作者：
Javorsky, M. [1 ,2 ]
Gotthardova, I. [1 ]
Klimcakova, L. [3 ]
Kvapil, M. [4 ,5 ]
Schroner, Z. [1 ]
Doubravova, P. [4 ]
Zidzik, J. [3 ]
Gal'a, I. [1 ]
Dravecka, I. [6 ]
Tkac, I. [1 ]
机构：
[1] Safarik Univ, Sch Med, Dept Med 4, Kosice, Slovakia
[2] Pasteur Teaching Hosp, Kosice, Slovakia
[3] Safarik Univ, Sch Med, Inst Med Biol & Genet, Kosice, Slovakia
[4] Fac Med 2, Prague, Czech Republic
[5] Fac Hosp Motol, Prague, Czech Republic
[6] Safarik Univ, Sch Med, Dept Med 1, Kosice, Slovakia
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
783
引用
收藏
页码：S373 / S374
页数：2
相关论文
共 50 条
  • [41] Retraction Note: therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment
    Alok Sharma
    Geetanjali Paliwal
    Nisha Upadhyay
    Archana Tiwari
    Journal of Diabetes & Metabolic Disorders, 15 (1):
  • [42] From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy
    Dicembrini, Ilaria
    Pala, Laura
    Rotella, Carlo Maria
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [43] Comparison between Clinical Efficacy of DPP-4 Inhibitors and GLP-1 Analogs in Type 2 Diabetics
    Faber-Heinemann, G.
    DIABETES STOFFWECHSEL UND HERZ, 2012, 21 (06): : 357 - 368
  • [44] Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
    Berthold Hocher
    Oleg Tsuprykov
    Nature Reviews Nephrology, 2017, 13 : 728 - 730
  • [45] Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
    Hocher, Berthold
    Tsuprykov, Oleg
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (12) : 728 - 729
  • [46] The CTRB1/CTRB2/BCAR1 locus is associated with GLP-1 stimulated insulin secretion and DPP-4 inhibitor treatment response
    't Hart, L. M.
    Fritsche, A.
    van Leeuwen, N.
    Nijpels, G.
    Donnelly, L. A.
    Dekker, J. M.
    Fadista, J.
    Groop, L.
    Carlotti, F.
    de Koning, E. J. P.
    Boomsma, D. I.
    de Geus, E. J. C.
    Eekhoff, E. M. W.
    Pearson, E. R.
    Diamant, M.
    DIABETOLOGIA, 2013, 56 : S154 - S154
  • [47] Insulin resistance and high fasting glucose are associated with reduced glycaemic response to dipeptidyl peptidase 4 (DPP-4) inhibitor therapy
    Jones, A. G.
    Hill, A. V.
    Bolt, R.
    McDonald, T. J.
    Shields, B. M.
    Knight, B. A.
    Hattersley, A. T.
    DIABETIC MEDICINE, 2015, 32 : 17 - 17
  • [48] Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease
    Panchapakesan, Usha
    Mather, Amanda
    Pollock, Carol
    CLINICAL SCIENCE, 2013, 124 (1-2) : 17 - 26
  • [49] Genetic Association of DPP4 C/T and GLP1R C/A with Cytokines and Hormones in Undiagnosed Diabetic Subjects
    Waris, Nazish
    Nangrejo, Ruqaya
    Bano, Samina
    Kamran, Muhammad
    Fawwad, Asher
    Basit, Abdul
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2023, 22 (01): : 22 - 28
  • [50] Comparative Effectiveness of SGLT-2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Agonists in US Veterans with and Without CKD
    Narasaki, Yoko
    Kovesdy, Csaba P.
    You, Amy S.
    Potukuchi, Praveen Kumar
    Dashputre, Ankur A.
    Sumida, Keiichi
    Thomas, Fridtjof
    Streja, Elani
    Kalantar-Zadeh, Kamyar
    Rhee, Connie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 264 - 264
12345